Literature DB >> 30172836

Incident hand OA is strongly associated with reduced peripheral blood leukocyte telomere length.

T McAlindon1, M Roberts2, J Driban3, L Schaefer4, I K Haugen5, S E Smith6, J Duryea7, D Cunha8, F Blanco9, J-L Fernández-Garcia10, C Eaton11.   

Abstract

OBJECTIVE: To evaluate the relationship of telomere length to the prevalence and incidence of hand osteoarthritis in a longitudinal cohort.
DESIGN: We conducted a cross-sectional and longitudinal analysis of data from a subset of participants in the Osteoarthritis Initiative (OAI) recruited between February 2004 and May 2006. 274 individuals were eligible for the study based on availability of both baseline and 48-month hand radiographs and peripheral blood leucocyte telomere length data. Mean telomere length of peripheral blood leukocytes (PBL)s from the DNA samples was determined using a validated quantitative polymerase chain reaction (PCR)-based assay, and hand radiographs were analyzed and graded using the Kellgren-Lawrence scale.
RESULTS: In joint -level analyses, prevalent Interphalangeal Joint Osteoarthritis (IPJOA) was significantly associated with PBL telomere length in the baseline sample in unadjusted analyses (RR = 2.84; 95% CI:0.87-9.29) or in models adjusted for age, sex, and body mass index (aRR = 1.10; 95% CI: 0.96-1.27). The association in crude and adjusted analyses appeared slightly stronger with incident IPJOA, especially in the subset with normal hands at baseline (aRR = 1.62; 95% CI: 1.02-2.57). PBL telomere length was also associated with prevalent HOA at baseline (significant in unadjusted analysis: RR = 1.22; 95% CI 1.06-1.42), but not after adjusting for covariates: aRR = 1.12; 95% CI: 0.96-1.30). The magnitude of association was stronger for incident HOA, especially incident symptomatic HOA (aRR = 1.53; 95% CI: 1.09-2.15).
CONCLUSIONS: In summary, the results of this exploratory analysis are confirmatory of previous work showing a cross-sectional relationship between telomere length and HOA and add to the field by demonstrating an even stronger association with incident IPJOA, both radiographic and symptomatic.
Copyright © 2018 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiology; Hand; Osteoarthritis; Telomere

Mesh:

Year:  2018        PMID: 30172836      PMCID: PMC6345164          DOI: 10.1016/j.joca.2018.08.010

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  43 in total

1.  Estimating the relative risk in cohort studies and clinical trials of common outcomes.

Authors:  Louise-Anne McNutt; Chuntao Wu; Xiaonan Xue; Jean Paul Hafner
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

2.  Raising the bar on telomere epidemiology.

Authors:  Silvia Ehrlenbach; Peter Willeit; Stefan Kiechl; Johann Willeit; Markus Reindl; Kathrin Schanda; Florian Kronenberg; Anita Brandstätter
Journal:  Int J Epidemiol       Date:  2010-01-08       Impact factor: 7.196

3.  Fifteen-year follow-up of association between telomere length and incident cancer and cancer mortality.

Authors:  Peter Willeit; Johann Willeit; Anita Kloss-Brandstätter; Florian Kronenberg; Stefan Kiechl
Journal:  JAMA       Date:  2011-07-06       Impact factor: 56.272

4.  Prevalence, incidence and progression of hand osteoarthritis in the general population: the Framingham Osteoarthritis Study.

Authors:  Ida K Haugen; Martin Englund; Piran Aliabadi; Jingbo Niu; Margaret Clancy; Tore K Kvien; David T Felson
Journal:  Ann Rheum Dis       Date:  2011-05-27       Impact factor: 19.103

5.  Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay.

Authors:  Silvia Ehrlenbach; Peter Willeit; Stefan Kiechl; Johann Willeit; Markus Reindl; Kathrin Schanda; Florian Kronenberg; Anita Brandstätter
Journal:  Int J Epidemiol       Date:  2009-08-07       Impact factor: 7.196

6.  Decreased length of telomeric DNA sequences and increased numerical chromosome aberrations in human osteoarthritic chondrocytes.

Authors:  María Tamayo; Alejandro Mosquera; Ignacio Rego; Francisco J Blanco; Jaime Gosálvez; José Luis Fernández
Journal:  Mutat Res       Date:  2011-02-01       Impact factor: 2.433

7.  Telomere length and risk of incident cancer and cancer mortality.

Authors:  Peter Willeit; Johann Willeit; Agnes Mayr; Siegfried Weger; Friedrich Oberhollenzer; Anita Brandstätter; Florian Kronenberg; Stefan Kiechl
Journal:  JAMA       Date:  2010-07-07       Impact factor: 56.272

Review 8.  Mitochondrial DNA haplogroups influence the risk of incident knee osteoarthritis in OAI and CHECK cohorts. A meta-analysis and functional study.

Authors:  Mercedes Fernández-Moreno; Angel Soto-Hermida; María E Vázquez-Mosquera; Estefanía Cortés-Pereira; Sara Relaño; Tamara Hermida-Gómez; Sonia Pértega; Natividad Oreiro-Villar; Carlos Fernández-López; Rafael Garesse; Francisco J Blanco; Ignacio Rego-Pérez
Journal:  Ann Rheum Dis       Date:  2016-12-05       Impact factor: 19.103

9.  Association of relative telomere length with progression of chronic kidney disease in two cohorts: effect modification by smoking and diabetes.

Authors:  Julia Raschenberger; Barbara Kollerits; James Ritchie; Beverley Lane; Philip A Kalra; Eberhard Ritz; Florian Kronenberg
Journal:  Sci Rep       Date:  2015-07-07       Impact factor: 4.379

Review 10.  Impact of senescence-associated secretory phenotype and its potential as a therapeutic target for senescence-associated diseases.

Authors:  Sugiko Watanabe; Shimpei Kawamoto; Naoko Ohtani; Eiji Hara
Journal:  Cancer Sci       Date:  2017-04-18       Impact factor: 6.716

View more
  1 in total

Review 1.  Telomere length and telomerase activity in osteoporosis and osteoarthritis.

Authors:  Persefoni Fragkiadaki; Dragana Nikitovic; Katerina Kalliantasi; Evangelia Sarandi; Maria Thanasoula; Polychronis D Stivaktakis; Charitini Nepka; Demetrios A Spandidos; Theodoros Tosounidis; Aristidis Tsatsakis
Journal:  Exp Ther Med       Date:  2019-12-24       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.